26
Jan

NPS Pharma picked up FDA approval for the rare disease-treating Natpara, capping a lengthy review process and supporting Shire’s decision to spend $5.2 billion on the company.

…read more

Source: FDA approves NPS Pharma’s drug, burnishing Shire’s $5.2B bet

    

0 No comments